XNAS 01 May, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Leesa Gentry | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2026 | 128,550 | 128,550 | - | - | Stock Option | |
| Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2026 | 621,727 | 621,727 | - | - | Stock Option | |
| Shaun R. Bagai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2026 | 946,107 | 946,107 | - | - | Stock Option | |
| Mark Voll | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2026 | 80,000 | 117,380 | - | 0 | Common Stock | |
| Mark Voll | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2026 | 12,380 | 37,380 | - | 0 | Common Stock | |
| Mark Voll | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 97,200 | 97,200 | - | - | Common Stock | |
| Mark Voll | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 48,600 | 48,600 | - | - | Warrants | |
| Laurence J. Marton | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 9,720 | 9,720 | - | - | Common Stock | |
| Laurence J. Marton | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 4,860 | 4,860 | - | - | Warrants | |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 12,150 | 12,150 | - | - | Warrants | |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Mar 2026 | 24,300 | 313,357 | - | - | Common Stock | |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 21 Jan 2026 | 10,000 | 798,460 | - | 1.0 | 9,975 | Common Stock |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 31 Dec 2025 | 9,795 | 788,460 | - | 0.9 | 8,424 | Common Stock |
| Agah Ramtin | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 30 Dec 2025 | 205 | 778,665 | - | 0.8 | 169 | Common Stock |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 18 Dec 2025 | 5,000 | 340,040 | - | 0.9 | 4,507 | Common Stock |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 17 Dec 2025 | 5,000 | 335,040 | - | 0.9 | 4,262 | Common Stock |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 16 Dec 2025 | 12,000 | 778,460 | - | 0.9 | 10,200 | Common Stock |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 05 Dec 2025 | 10,000 | 766,460 | - | 1.0 | 9,600 | Common Stock |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 21 Nov 2025 | 10,000 | 744,460 | - | 0.8 | 8,000 | Common Stock |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 21 Nov 2025 | 12,000 | 756,460 | - | 0.8 | 9,600 | Common Stock |
| Ryan Una S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 47,640 | 47,640 | - | - | Stock Options (right to buy) | |
| Marton J. Laurence | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 47,640 | 47,640 | - | - | Stock Options (right to buy) | |
| Jay Spiegel Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 47,640 | 47,640 | - | - | Stock Options (right to buy) | |
| Kirsten Macfarlane Angela | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 47,640 | 47,640 | - | - | Stock Options (right to buy) | |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 22 Aug 2025 | 5,000 | 325,040 | - | 0.9 | 4,748 | Common Stock |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 22 Aug 2025 | 5,000 | 330,040 | - | 0.9 | 4,549 | Common Stock |
| Leesa Gentry | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 6,619 | 6,619 | - | - | Stock Option | |
| Ronald B. Kocak | VP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 41,600 | 41,600 | - | - | Stock Option | |
| Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 63,636 | 63,636 | - | - | Stock Option | |
| Shaun R. Bagai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 102,498 | 102,498 | - | - | Stock Option | |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.40 per share. | 05 Jun 2025 | 21,000 | 734,460 | - | 1.4 | 29,400 | Common Stock |
| Laurence J. Marton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.15 per share. | 02 May 2025 | 20,480 | 66,164 | - | 0.2 | 3,072 | Common Stock |
| Laurence J. Marton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 20,480 | 0 | - | - | Stock Option (right to buy) | |
| Ramtin Agah | Director, Chief Medical Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Apr 2025 | 400,000 | 713,460 | - | 0 | Common Stock | |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 15 Apr 2025 | 7,500 | 320,040 | - | 0.9 | 6,821 | Common Stock |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 15 Apr 2025 | 15,000 | 1,113,460 | - | 0.9 | 13,500 | Common Stock |
| Leesa Gentry | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 26,477 | 26,477 | - | - | Stock Option | |
| Shaun R. Bagai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 409,992 | 409,992 | - | - | Stock Option | |
| Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 254,542 | 254,542 | - | - | Stock Option | |
| Ronald B. Kocak | VP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2025 | 166,400 | 166,400 | - | - | Stock Option | |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 11 Apr 2025 | 20,000 | 1,098,460 | - | 0.8 | 16,000 | Common Stock |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 09 Apr 2025 | 30,000 | 1,078,460 | - | 0.8 | 24,399 | Common Stock |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 09 Apr 2025 | 10,000 | 312,540 | - | 0.8 | 8,300 | Common Stock |
| Ronald B. Kocak | VP Controller and PAO | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 08 Apr 2025 | 6,000 | 6,095 | - | 0.8 | 4,800 | Common Stock |
| Ronald B. Kocak | VP Controller and PAO | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 08 Apr 2025 | 95 | 95 | - | 0.8 | 76 | Common Stock |
| Ronald B. Kocak | VP Controller and PAO | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 08 Apr 2025 | 6,500 | 12,595 | - | 0.8 | 5,135 | Common Stock |
| Laurence J. Marton | Director | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 08 Apr 2025 | 12,050 | 45,684 | - | 0.8 | 10,218 | Common Stock |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 08 Apr 2025 | 26,000 | 1,048,460 | - | 0.8 | 21,840 | Common Stock |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 07 Apr 2025 | 10,000 | 302,540 | - | 0.8 | 8,300 | Common Stock |
| Kirsten Angela Macfarlane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 25,099 | 25,099 | - | - | Stock Options (right to buy) | |
| Robert J. Spiegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 25,099 | 25,099 | - | - | Stock Options (right to buy) | |
| Laurence J. Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 25,099 | 25,099 | - | - | Stock Options (right to buy) | |
| Una S. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 25,099 | 25,099 | - | - | Stock Options (right to buy) | |
| Leesa Gentry | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 190,000 | 190,000 | - | - | Options | |
| B. Ronald Kocak | VP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 15,000 | 15,000 | - | - | Options | |
| J. Marton Laurence | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 8,196 | 8,196 | - | - | Warrants | |
| R. Bagai Shaun | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Warrants | |
| Marton Laurence J. | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 8,196 | 33,634 | - | - | Common Stock | |
| J. Robert Spiegel | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Warrants | |
| Agah Ramtin | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Warrants | |
| Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 47,460 | - | - | Common Stock | |
| Macfarlane Angela Kirsten | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Warrant Shares | |
| R. Shaun Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 292,540 | - | - | Common Stock | |
| Robert Spiegel J. | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Common Stock | |
| Kirsten Macfarlane Angela | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Jan 2024 | 40,983 | 40,983 | - | - | Common Stock | |
| Angela Gill Nelms | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 125,132 | 125,132 | - | - | Stock Option | |
| Agah Ramtin | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 28,424 | 28,424 | - | - | Stock Option | |
| Nelms Angela Gill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 33,768 | 33,768 | - | - | Stock Option | |
| Bagai R. Shaun | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 66,973 | 66,973 | - | - | Stock Option | |
| Agah Ramtin | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 125,132 | 125,132 | - | - | Stock Option | |
| R. Shaun Bagai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2024 | 250,263 | 250,263 | - | - | Stock Option | |
| Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 65,000 | 65,000 | - | - | Employee Stock Option (right to buy) | |
| Shaun R. Bagai | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) | |
| Angela Gill Nelms | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2023 | 32,500 | 32,500 | - | - | Employee Stock Option (right to buy) | |
| Una S. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 25,099 | 25,099 | - | - | Stock Option (right to buy) | |
| Laurence J. Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 25,099 | 25,099 | - | - | Stock Option (right to buy) | |
| David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 25,099 | 25,099 | - | - | Stock Option (right to buy) | |
| Kirsten Angela Macfarlane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2022 | 25,099 | 25,099 | - | - | Stock Option (right to buy) | |
| Angela Gill Nelms | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2022 | 274,230 | 274,230 | - | - | Employee Stock Option (right to buy) | |
| Ramtin Agah | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2022 | 975,000 | 1,295 | - | 0 | Common Stock | |
| Ramtin Agah | Director, Chief Medical Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Jun 2022 | 975,000 | 975,000 | - | 0 | Common Stock | |
| Ramtin Agah | Director, Chief Medical Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 07 Jun 2022 | 5,182 | 6,477 | - | 1.9 | 10,001 | Common Stock |
| Shaun R. Bagai | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.05 per share. | 19 May 2022 | 5,500 | 251,557 | - | 2.1 | 11,275 | Common Stock |
| Una S. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 4,582 | 4,582 | - | - | Stock Option (right to buy) | |
| Laurence J. Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 4,582 | 4,582 | - | - | Stock Option (right to buy) | |
| David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 9,165 | 9,165 | - | - | Stock Option (right to buy) | |
| David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 4,582 | 4,582 | - | - | Stock Option (right to buy) | |
| Shaun R. Bagai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 48,313 | 48,313 | - | - | Employee Stock Option (right to buy) | |
| Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 21,398 | 21,398 | - | - | Employee Stock Option (right to buy) | |
| Kirsten Angela Macfarlane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 4,582 | 4,582 | - | - | Stock option (right to buy) | |
| Una S. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 11,154 | 11,154 | - | - | Stock Option (right to buy) | |
| Kristen Angela Macfarlane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 11,154 | 11,154 | - | - | Stock Option (right to buy) | |
| David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 22,307 | 22,307 | - | - | Stock Option (right to buy) | |
| David Diamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 11,154 | 33,461 | - | - | Stock Option (right to buy) | |
| Laurence Marton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 11,154 | 11,154 | - | - | Stock Option (right to buy) | |
| Ramtin Agah | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 52,203 | 52,203 | - | - | Employee Stock Option (right to buy) | |
| Shaun R. Bagai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 117,866 | 117,866 | - | - | Employee Stock Option (right to buy) |